CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Accelerator Nordic AB is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Accelerator Nordic AB
c/o Swedia Capital, Skinnarviksringen 16
Phone: +46 86635700p:+46 86635700 Stockholm, 117 27  Sweden Ticker: ACCEACCE
This company was Merged or Acquired on 12/12/2013.
Acquired by Nortal Investments AB
On 5/1/2015, Accelerator Nordic AB entered into voluntary liquidation.
This company is no longer actively traded on any major stock exchange.
Business Summary
Accelerator Nordic AB is a Sweden-based company active in the life science sector. It is engaged in holding activities and majority shareholder positions in companies focused on Imagining Software and Medical Nanotechnology. Its portfolio includes SyntheticMR AB, engaged in the development of analytical and visualization tools for magnetic resonance imaging, and OptoQ AB, engaged in the marketing of technology for patient-monitoring; Spago Imaging AB, engaged in the development of nano-particle based contrast agents for diagnostic imaging; AddBIO AB, engaged in the development and commercialization of products for local drug delivery, and Optovent AB, engaged in the development of platform technologies for drug delivery. In December 2013, Nortal Investments AB acquired shares in the Company, raising its stake from about 33% to approximately 51.6%. In February 2014, Nortal Investment AB increased its stake to 71.9% after completion of mandatory offer and purchase of shares and votes.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201412/31/2014Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board StaffanPersson 59 1/1/1999
Acting Chief Executive Officer, Director MonikaLundstrom 12/31/2014 1/1/2013
Chief Financial Officer MariaWengler
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
SyntheticMR AB (publ) Storgatan 11 LINKOPING Sweden

Business Names
Business Name
ACCE
ACCE-B
Accelerator i Linkoping AB
Accelerator Nordic AB

General Information
Number of Employees: 14 (As of 9/30/2013)
Outstanding Shares: 16,461,951 (As of 12/31/2014)
Shareholders: 1,899
Stock Exchange: STO
Fax Number: +46 86635725


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023